TheraRadar
← Back
Data updated: Jul 17, 2026

STRIDES ACROLAB

Pharma
Pharmaceuticals

STRIDES ACROLAB is a pharmaceutical company with 7 FDA-approved products.

-
Since
7
Drugs
-
Trials
0
New Drugs (2yr)

STRIDES ACROLAB's Key Drugs

STRIDES ACROLAB's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

STRIDES ACROLAB's Recent FDA Approvals

New NDA/BLA approvals for STRIDES ACROLAB over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

STRIDES ACROLAB's Therapeutic Areas

Disease areas where STRIDES ACROLAB has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

STRIDES ACROLAB Pipeline Snapshot

Active clinical trials for STRIDES ACROLAB across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling